Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 3 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 24 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 16 |
NetGPI | no | yes: 0, no: 16 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 3 |
GO:0005737 | cytoplasm | 2 | 3 |
GO:0043226 | organelle | 2 | 3 |
GO:0043227 | membrane-bounded organelle | 3 | 3 |
GO:0043229 | intracellular organelle | 3 | 3 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 3 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
Related structures:
AlphaFold database: A4HFV0
Term | Name | Level | Count |
---|---|---|---|
GO:0006468 | protein phosphorylation | 5 | 17 |
GO:0006793 | phosphorus metabolic process | 3 | 17 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 17 |
GO:0006807 | nitrogen compound metabolic process | 2 | 17 |
GO:0008152 | metabolic process | 1 | 17 |
GO:0009987 | cellular process | 1 | 17 |
GO:0016310 | phosphorylation | 5 | 17 |
GO:0019538 | protein metabolic process | 3 | 17 |
GO:0036211 | protein modification process | 4 | 17 |
GO:0043170 | macromolecule metabolic process | 3 | 17 |
GO:0043412 | macromolecule modification | 4 | 17 |
GO:0044237 | cellular metabolic process | 2 | 17 |
GO:0044238 | primary metabolic process | 2 | 17 |
GO:0071704 | organic substance metabolic process | 2 | 17 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 17 |
GO:0007165 | signal transduction | 2 | 3 |
GO:0018105 | peptidyl-serine phosphorylation | 6 | 3 |
GO:0018193 | peptidyl-amino acid modification | 5 | 3 |
GO:0018209 | peptidyl-serine modification | 6 | 3 |
GO:0050789 | regulation of biological process | 2 | 3 |
GO:0050794 | regulation of cellular process | 3 | 3 |
GO:0065007 | biological regulation | 1 | 3 |
GO:0006810 | transport | 3 | 2 |
GO:0006897 | endocytosis | 5 | 2 |
GO:0016192 | vesicle-mediated transport | 4 | 2 |
GO:0051179 | localization | 1 | 2 |
GO:0051234 | establishment of localization | 2 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000166 | nucleotide binding | 3 | 17 |
GO:0003824 | catalytic activity | 1 | 17 |
GO:0004672 | protein kinase activity | 3 | 17 |
GO:0005488 | binding | 1 | 17 |
GO:0005524 | ATP binding | 5 | 17 |
GO:0016301 | kinase activity | 4 | 17 |
GO:0016740 | transferase activity | 2 | 17 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 17 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 17 |
GO:0017076 | purine nucleotide binding | 4 | 17 |
GO:0030554 | adenyl nucleotide binding | 5 | 17 |
GO:0032553 | ribonucleotide binding | 3 | 17 |
GO:0032555 | purine ribonucleotide binding | 4 | 17 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 17 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 17 |
GO:0036094 | small molecule binding | 2 | 17 |
GO:0043167 | ion binding | 2 | 17 |
GO:0043168 | anion binding | 3 | 17 |
GO:0097159 | organic cyclic compound binding | 2 | 17 |
GO:0097367 | carbohydrate derivative binding | 2 | 17 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 17 |
GO:1901265 | nucleoside phosphate binding | 3 | 17 |
GO:1901363 | heterocyclic compound binding | 2 | 17 |
GO:0004674 | protein serine/threonine kinase activity | 4 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 408 | 412 | PF00656 | 0.342 |
CLV_C14_Caspase3-7 | 485 | 489 | PF00656 | 0.532 |
CLV_NRD_NRD_1 | 325 | 327 | PF00675 | 0.320 |
CLV_PCSK_KEX2_1 | 325 | 327 | PF00082 | 0.320 |
CLV_PCSK_KEX2_1 | 359 | 361 | PF00082 | 0.408 |
CLV_PCSK_PC1ET2_1 | 359 | 361 | PF00082 | 0.408 |
CLV_PCSK_SKI1_1 | 382 | 386 | PF00082 | 0.327 |
CLV_TASPASE1 | 486 | 492 | PF01112 | 0.525 |
DOC_ANK_TNKS_1 | 451 | 458 | PF00023 | 0.491 |
DOC_CKS1_1 | 307 | 312 | PF01111 | 0.238 |
DOC_CKS1_1 | 539 | 544 | PF01111 | 0.437 |
DOC_MAPK_DCC_7 | 116 | 124 | PF00069 | 0.230 |
DOC_MAPK_MEF2A_6 | 365 | 372 | PF00069 | 0.262 |
DOC_MAPK_NFAT4_5 | 365 | 373 | PF00069 | 0.253 |
DOC_PP2B_LxvP_1 | 23 | 26 | PF13499 | 0.474 |
DOC_PP2B_LxvP_1 | 79 | 82 | PF13499 | 0.495 |
DOC_PP4_FxxP_1 | 539 | 542 | PF00568 | 0.506 |
DOC_USP7_MATH_1 | 136 | 140 | PF00917 | 0.238 |
DOC_USP7_MATH_1 | 27 | 31 | PF00917 | 0.524 |
DOC_WW_Pin1_4 | 306 | 311 | PF00397 | 0.238 |
DOC_WW_Pin1_4 | 538 | 543 | PF00397 | 0.498 |
DOC_WW_Pin1_4 | 549 | 554 | PF00397 | 0.439 |
DOC_WW_Pin1_4 | 60 | 65 | PF00397 | 0.520 |
LIG_14-3-3_CanoR_1 | 128 | 136 | PF00244 | 0.304 |
LIG_14-3-3_CanoR_1 | 234 | 238 | PF00244 | 0.297 |
LIG_14-3-3_CanoR_1 | 311 | 316 | PF00244 | 0.315 |
LIG_14-3-3_CanoR_1 | 95 | 99 | PF00244 | 0.333 |
LIG_Actin_WH2_2 | 397 | 412 | PF00022 | 0.303 |
LIG_BIR_III_2 | 523 | 527 | PF00653 | 0.535 |
LIG_BIR_III_4 | 510 | 514 | PF00653 | 0.536 |
LIG_BRCT_BRCA1_1 | 103 | 107 | PF00533 | 0.238 |
LIG_BRCT_BRCA1_1 | 138 | 142 | PF00533 | 0.238 |
LIG_BRCT_BRCA1_1 | 286 | 290 | PF00533 | 0.257 |
LIG_eIF4E_1 | 334 | 340 | PF01652 | 0.238 |
LIG_EVH1_1 | 23 | 27 | PF00568 | 0.475 |
LIG_EVH1_1 | 539 | 543 | PF00568 | 0.436 |
LIG_FHA_1 | 238 | 244 | PF00498 | 0.238 |
LIG_FHA_1 | 427 | 433 | PF00498 | 0.498 |
LIG_FHA_1 | 443 | 449 | PF00498 | 0.481 |
LIG_FHA_1 | 475 | 481 | PF00498 | 0.527 |
LIG_FHA_1 | 539 | 545 | PF00498 | 0.438 |
LIG_FHA_1 | 67 | 73 | PF00498 | 0.492 |
LIG_FHA_2 | 95 | 101 | PF00498 | 0.260 |
LIG_LIR_Apic_2 | 536 | 542 | PF02991 | 0.447 |
LIG_LIR_Gen_1 | 236 | 244 | PF02991 | 0.243 |
LIG_LIR_Gen_1 | 309 | 319 | PF02991 | 0.251 |
LIG_LIR_Gen_1 | 396 | 406 | PF02991 | 0.356 |
LIG_LIR_Gen_1 | 97 | 107 | PF02991 | 0.187 |
LIG_LIR_Nem_3 | 104 | 110 | PF02991 | 0.306 |
LIG_LIR_Nem_3 | 236 | 241 | PF02991 | 0.275 |
LIG_LIR_Nem_3 | 309 | 315 | PF02991 | 0.295 |
LIG_LIR_Nem_3 | 379 | 384 | PF02991 | 0.365 |
LIG_LIR_Nem_3 | 396 | 402 | PF02991 | 0.454 |
LIG_LIR_Nem_3 | 97 | 102 | PF02991 | 0.307 |
LIG_NRBOX | 401 | 407 | PF00104 | 0.294 |
LIG_PCNA_yPIPBox_3 | 203 | 216 | PF02747 | 0.257 |
LIG_Pex14_2 | 92 | 96 | PF04695 | 0.390 |
LIG_PTB_Apo_2 | 300 | 307 | PF02174 | 0.257 |
LIG_SH2_CRK | 312 | 316 | PF00017 | 0.251 |
LIG_SH2_CRK | 399 | 403 | PF00017 | 0.456 |
LIG_SH2_PTP2 | 334 | 337 | PF00017 | 0.257 |
LIG_SH2_SRC | 259 | 262 | PF00017 | 0.273 |
LIG_SH2_STAP1 | 387 | 391 | PF00017 | 0.338 |
LIG_SH2_STAT3 | 206 | 209 | PF00017 | 0.257 |
LIG_SH2_STAT3 | 49 | 52 | PF00017 | 0.593 |
LIG_SH2_STAT5 | 259 | 262 | PF00017 | 0.301 |
LIG_SH2_STAT5 | 280 | 283 | PF00017 | 0.320 |
LIG_SH2_STAT5 | 321 | 324 | PF00017 | 0.269 |
LIG_SH2_STAT5 | 334 | 337 | PF00017 | 0.397 |
LIG_SH2_STAT5 | 338 | 341 | PF00017 | 0.450 |
LIG_SH3_3 | 18 | 24 | PF00018 | 0.524 |
LIG_SH3_3 | 537 | 543 | PF00018 | 0.463 |
LIG_SUMO_SIM_anti_2 | 240 | 245 | PF11976 | 0.187 |
LIG_SUMO_SIM_par_1 | 239 | 245 | PF11976 | 0.286 |
LIG_TRAF2_1 | 194 | 197 | PF00917 | 0.230 |
LIG_TYR_ITIM | 332 | 337 | PF00017 | 0.238 |
MOD_CDK_SPK_2 | 306 | 311 | PF00069 | 0.238 |
MOD_CDK_SPxxK_3 | 549 | 556 | PF00069 | 0.487 |
MOD_CK1_1 | 314 | 320 | PF00069 | 0.286 |
MOD_CK1_1 | 419 | 425 | PF00069 | 0.470 |
MOD_CK1_1 | 499 | 505 | PF00069 | 0.589 |
MOD_CK1_1 | 538 | 544 | PF00069 | 0.440 |
MOD_CK2_1 | 246 | 252 | PF00069 | 0.186 |
MOD_GlcNHglycan | 103 | 106 | PF01048 | 0.254 |
MOD_GlcNHglycan | 178 | 181 | PF01048 | 0.268 |
MOD_GlcNHglycan | 346 | 349 | PF01048 | 0.238 |
MOD_GlcNHglycan | 424 | 427 | PF01048 | 0.507 |
MOD_GlcNHglycan | 453 | 456 | PF01048 | 0.537 |
MOD_GlcNHglycan | 480 | 483 | PF01048 | 0.512 |
MOD_GlcNHglycan | 517 | 520 | PF01048 | 0.559 |
MOD_GlcNHglycan | 527 | 530 | PF01048 | 0.500 |
MOD_GlcNHglycan | 64 | 67 | PF01048 | 0.498 |
MOD_GSK3_1 | 158 | 165 | PF00069 | 0.217 |
MOD_GSK3_1 | 233 | 240 | PF00069 | 0.267 |
MOD_GSK3_1 | 302 | 309 | PF00069 | 0.349 |
MOD_GSK3_1 | 405 | 412 | PF00069 | 0.356 |
MOD_GSK3_1 | 415 | 422 | PF00069 | 0.464 |
MOD_GSK3_1 | 474 | 481 | PF00069 | 0.651 |
MOD_GSK3_1 | 495 | 502 | PF00069 | 0.738 |
MOD_GSK3_1 | 515 | 522 | PF00069 | 0.524 |
MOD_GSK3_1 | 62 | 69 | PF00069 | 0.503 |
MOD_N-GLC_1 | 302 | 307 | PF02516 | 0.257 |
MOD_N-GLC_1 | 519 | 524 | PF02516 | 0.644 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.568 |
MOD_NEK2_1 | 216 | 221 | PF00069 | 0.240 |
MOD_NEK2_1 | 237 | 242 | PF00069 | 0.266 |
MOD_NEK2_1 | 284 | 289 | PF00069 | 0.238 |
MOD_NEK2_1 | 319 | 324 | PF00069 | 0.273 |
MOD_NEK2_1 | 405 | 410 | PF00069 | 0.353 |
MOD_NEK2_1 | 415 | 420 | PF00069 | 0.540 |
MOD_NEK2_1 | 495 | 500 | PF00069 | 0.683 |
MOD_NEK2_2 | 94 | 99 | PF00069 | 0.285 |
MOD_PIKK_1 | 158 | 164 | PF00454 | 0.198 |
MOD_PIKK_1 | 51 | 57 | PF00454 | 0.672 |
MOD_PKA_2 | 127 | 133 | PF00069 | 0.257 |
MOD_PKA_2 | 233 | 239 | PF00069 | 0.286 |
MOD_PKA_2 | 409 | 415 | PF00069 | 0.364 |
MOD_PKA_2 | 451 | 457 | PF00069 | 0.547 |
MOD_PKA_2 | 495 | 501 | PF00069 | 0.553 |
MOD_PKA_2 | 94 | 100 | PF00069 | 0.338 |
MOD_Plk_1 | 136 | 142 | PF00069 | 0.238 |
MOD_Plk_1 | 302 | 308 | PF00069 | 0.257 |
MOD_Plk_1 | 535 | 541 | PF00069 | 0.452 |
MOD_Plk_4 | 136 | 142 | PF00069 | 0.238 |
MOD_Plk_4 | 233 | 239 | PF00069 | 0.280 |
MOD_Plk_4 | 302 | 308 | PF00069 | 0.257 |
MOD_Plk_4 | 87 | 93 | PF00069 | 0.420 |
MOD_ProDKin_1 | 306 | 312 | PF00069 | 0.238 |
MOD_ProDKin_1 | 538 | 544 | PF00069 | 0.498 |
MOD_ProDKin_1 | 549 | 555 | PF00069 | 0.435 |
MOD_ProDKin_1 | 60 | 66 | PF00069 | 0.518 |
MOD_SUMO_for_1 | 124 | 127 | PF00179 | 0.320 |
MOD_SUMO_for_1 | 264 | 267 | PF00179 | 0.370 |
MOD_SUMO_rev_2 | 139 | 148 | PF00179 | 0.280 |
TRG_DiLeu_BaEn_1 | 277 | 282 | PF01217 | 0.238 |
TRG_DiLeu_BaLyEn_6 | 296 | 301 | PF01217 | 0.230 |
TRG_ENDOCYTIC_2 | 312 | 315 | PF00928 | 0.295 |
TRG_ENDOCYTIC_2 | 334 | 337 | PF00928 | 0.238 |
TRG_ENDOCYTIC_2 | 399 | 402 | PF00928 | 0.365 |
TRG_ER_diArg_1 | 340 | 343 | PF00400 | 0.238 |
TRG_NES_CRM1_1 | 233 | 245 | PF08389 | 0.187 |
TRG_NES_CRM1_1 | 277 | 292 | PF08389 | 0.238 |
TRG_Pf-PMV_PEXEL_1 | 146 | 150 | PF00026 | 0.256 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IKB0 | Leptomonas seymouri | 60% | 98% |
A0A3Q8ISA0 | Leishmania donovani | 33% | 100% |
A0A3S7WZA2 | Leishmania donovani | 31% | 100% |
A0A3S7X0V1 | Leishmania donovani | 76% | 98% |
A4HEI6 | Leishmania braziliensis | 31% | 100% |
A4HIT6 | Leishmania braziliensis | 32% | 100% |
A4I1K4 | Leishmania infantum | 31% | 100% |
A4I2Y4 | Leishmania infantum | 76% | 98% |
A4I638 | Leishmania infantum | 33% | 100% |
E9ADF5 | Leishmania major | 77% | 100% |
E9AXN8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 31% | 100% |
E9AZ78 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 75% | 98% |
E9B1C3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 32% | 100% |
P42158 | Arabidopsis thaliana | 27% | 100% |
Q4Q6U1 | Leishmania major | 31% | 100% |
Q4Q9T3 | Leishmania major | 32% | 100% |
Q8LPI7 | Arabidopsis thaliana | 28% | 100% |